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SUMMARY: We utilized the technique of polymerase chain reaction with oligonucleotide primers 
based upon the nucleotide sequence of the canine I-I2 histamine receptor gene which we recently 
isolated to clone its human homologue. Transfection of a construct of this gene in Colo320 DM 
cells led to the expression of a receptor that bound to [methyl-3H] tiotidine and was linked to 3’,5’ 
cyclic adenosine monophosphate (CAMP) generation in response to histamine. Both CAMP 
generation and [methyl-3H] tiotidine biiing were inhibited with the H2 histamine receptor 
selective antagonist cimetidine but not diphenhydramine or thioperamide which are, respectively, 
Hl and H3 histamine receptor antagonists. These data confirm that we have successfully cloned a 
novel gene encoding the human II2 histamine receptor. 0 1991 Academic Press. Inc. 
The importance of histamine inthe regulation of gastric acid secretion was confirmed by the 
development of an antagonist that was specific for a subtype of histamine receptor subclass of 
histamine receptors labeled I-I2 (1). Indeed, the development of I-I2 receptor antagonists had a 
profound effect on the treatment of peptic ulcerdisease. Despite the extraordinary physiological 
and pharmacological significance of the I-E histamine receptor, little is known about its structure or 
function in man. Recently we cloned a gene encoding the canine gastric parietal cell IX? histamine 
receptor using the techniques of polymerase chain reaction (PCR) with degenerate oligonucleotide 
primers based upon homology tc iFher receptors known to be linked to guanine nucleotide binding 
proteins (2). In the current report we have utilized this gene to clone the human homologue of the 
canine IX? receptor and by expressing it in a human colon cancer cell line (CoIo-320 DM), we have 
confirmed its identity. 
MATERIALS AND METHODS 
Isolation of RNA. Human gastric fundic mucosa was obtained from a fresh surgical specimen 
and placed into liquid nitrogen for storage. The frozen tissue was pulverized and total RNA was 
extracted by the acid guanidinium tbiocyanate-phenol-chloroform method (3). Poly A+ RNA 
obtained by oligo d(T) celhtlose chromatography of the total RNA served as a template for cDNA 
synthesis using the avian myeloblastosis virus reverse transcriptase (Seikagaku, Rockville, 
The cDNA thus obtained functioned as a 
MD.). 
template for the polymerase chain reaction with the 
oligonucleotide primers described below. 
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Polymerase Chain Reaction. Three heptadecanucleotides that had been used to sequence the 
canine H2 clone were pooled and used as 5’ PCR primers (SCAGGATGATATCIAACG3’, 
S’GTGTCGTIGGCI’ATCAC’, 5’TCCATlCITAACCKIT3’) (2). A reverse complement 
heptadecanucleotide which was a degenerate oligonucleotide cortesponding to an ama in the fifth 
transmembrane domain of the canine H2 receptor (S’AAXGTXACYAZYCCZKZ?; X=G or I, 
Y=C OT I, Z=G or A) was used as the 3’ PCR primer. All oligonucleotides were synthesized by 
the Molecular Biology Core of the University of Michigan Gastrointestinal Peptide Research 
Center using an Applied Biosystems 380B DNA synthesizer. The conditions for the polymerase 
chain reaction were as follows: denaturation for 1.5 min at 94 ‘C!, annealing for 2 min at 45 ‘C, 
and extension for 4 min at 72 ‘C. The reaction was carried out for 30 cycles and then 20% of the 
product was added to fresh buffer and subjected to another 30 cycles. The final reaction products 
were phenol extracted and then ethanol precipitated. The DNA was blunt-ended via the Klenow 
reaction and the products of the reaction were electrophoresed on a 1% NuSieve, 1% Seaplaque gel 
(FMC;, Rockland, ME). Two bands of approximately 575 bp and 400 bp (Figure 1) were 
obtained. The larger band was cut out of the gel and subcloned directly into the Ml 3 sequencing 
vector (4). Dideoxynucleotide sequencing was then performed by the chain termination method of 
Sanger (5) using Sequenase Version 2 (USB, Cleveland, Ohio). 
Genomic Cloning. The partial length PCR derived clone was random primed (6) with 32P and 
used as a probe to screen a human genomic library (Clontech. Palo Alto, CA). Under high 
stringency hybridization [0.9M sodium chloride 0.09M sodium citrate (6xSSC), 65 ‘C] and wash 
conditions 10. lx SSC, 55 ‘C] a single clone exhibited a positive hybridization signal with the 
probe. The DNA insert in this clone was mapped with restriction endonucleases and a fragment 
flanked by two Pst I sites that contained the sequence derived by polymerase chain reaction was 
inserted into the Ml3 vector and itsnucleotide sequence obtained. A second fragment flanked by 
two Pst I sites corresponding to the 3’ portion of the coding region (bp 916 to the stop codon) 
and a portion of the untranslated 3’ region of the gene was also subcloned into Ml3 for nucleotide 
sequencing. 
Expression Experiments. The presumed full length coding region of the receptor gene was 
subcloned into CMVneo, a PUC13 based vector that also contains the lacUVS-SV40 promoter 
(440 bp), TnS-neo (1400 bp), SV40 splice site and polyadenylation signal (320 bp), CMV 
promoter (700 bp) and human growth hormone polyadenylation signal (700 bp) (7). Cultures of 
the human colonic adenocarcinoma cell line Colo32ODM (American Type Culture Collection, CCL 
220) were transfected with this vector using the technique of calcium phosphate co-precipitation 
(8). Permanently uansfected Colo-320 DM clones were selected by adding 1 m&ml of the 
neomycin analogue G418 to the culture medium. For binding studies, the selected clones were 
plated and grown to confluence in 2.4 x 1.7 cm multi-well plates. The culture medium was 
removed and cells were washed twice with Earle’s balanced salt solution containing 0.1% bovine 
serum albumin. An aliquot (36 nCi) of [methyl-3H]-tiotidine (87 Ci/mmol; Dupont, Boston MA) 
was added to the cultures in the presence of either cimetidine or diphenhydramine and after one 
hour of incubation, the medium was removed by aspiration. The cells were washed twice with 0.2 
Fip;urc 1. Gel (1% Nusieve, 1% Seaplaque) electrophoresis of polymemse chain reaction products 
from human gastric fundus mucosa (left lane). The size markers are included in the right lane. 
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M sodium phosphate 0.15 M NaCl, pH 7.4, lysed with 1% Triton X-100, and the radioactivity 
was quantified. Maximum binding was determined by incubation of [methyl-WI-tiotidine with 
transformed Colo-320DM cells in the absence of antagonists. Non-specific binding, which was 
subtracted from total binding to obtain specific binding, was determined as the amount of label 
remaining bound in the presence of 105 cimetidine. Transfected cells were incubated in Earle’s 
balanced salt solution with varying concentrations of histamine for 60 min at 37°C after a 60 min 
pm-incubation in medium with or without addition of cimetidine (10-t M). Ice cold 30% 
trichloroacetic acid was added to stop the reaction and precipitate the cellular protein. After 
centrifugation for 10 min at 1900x g, the supematant was ether extracted, lyophilized, and re- 
suspended in 50 mM Tris, 2 mM EDTA, pH 7.5. The content of 3’,5’ cyclic adenosine 
monophosphate (CAMP) was measured by competitive protein binding assay using an Amersham 
kit (Arlington Heights, 11). 
Northern Blotting. Total RNA was obtained by the acid guanidinium method and 
hybridization was performed using conditions previously described (9). The presumed coding 
region of the receptor gene that had been labeled with 32P by random priming served as the probe. 
RESULTS AND DISCUSSION 
Of the four clones obtained by subcloning the 575 bp PCR fragment into M13, one clone 
had approximately 83% nucleotide homology to a region of the gene encoding the canine histamine 
I-I2 receptor. Using this clone as a probe to screen a human genomic library, we obtained a full 
length clone that exhibited 88% nucleotide homology with the canine histamine H2 receptor gene 
(Figure 2). The amino acid homology (87%) of the proteins encoded by the two clones is 
comparable (Figure 3) with 92% overall similarity when conservative amino acid substitutions are 
considered. The regions of greatest homology between the two clones were the putative 
transmembrane regions of the receptor (table I). Studies by mutational analysis of the beta 
adrenergic receptor have indicated that two serine residues in the fifth transmembrane receptor are 
important for catecholamine binding. By analogy, the Asp186 and Thrlm in the fifth 
transmembrane domain of the canine histamine H2 receptor may have the potential to interact by 
hydrogen bonding with the imidazole ring of the histamine molecule. This particular region of the 
cloned human gene (Vall85 - Leu193) exhibited 100% homology at both the nucleotide and amino 
acid levels with the canine histamine H2 receptor gene. Northern blot analysis of human fundic 
mucosa (Figure 4) revealed a band of hybridization of approximately 4.8 Kb which corresponds to 
the predominant messenger RNA in the canine fundus (2). 
To confvm the identity of this human gene that we obtained and demonstrated to be 
homologous to the canine histamine H2 receptor, we expressed the gene in a human cell line 
(Colo-320DM) and conducted functional assays. As shown in Figure 5, cimetidine, an H2 
selective antagonist, displaced the binding of [methyl-3IIj tiotidine (another I-I2 receptor 
antagonist) to cells transfected with the human gene construct in a dose dependent fashion with an 
ED50 of 5 x 10-8 M. In contrast, neither the Hl histamine receptor antagonist diphenhydramine 
nor the H3 histamine receptor antagonist thioperamide were able to displace labeled tiotidine 
binding. As shown in Figure 6, transfected cells demonstrated dosedependent increases in 
cellular CAMP content in response to histamine stimulation reaching a maximum of 366k 40% of 
control (mean f SE, n=3) at the 10-S M histamine dose. Control non-uansfected Colo-320 DM 
cells failed to de~nstrate a response to histamine. These data confirm that the gene that we cloned 
encoded the human homologue of the canine H2 histamine receptor. Although in the published 
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1 ATGGCACCCAATGGCACAGCCTCTTCCTTTTGCCTGGACTCTACCGCATGCAAGATCACC 60 
A T T T  C G T  C TC G T  
I 
61 ATCACCGTGGTCCTTGCGGTCCTCATCCTCATCACCGTTGCTGGCAATGTGGTCGTCTGT 120 
G G CA T  AC C G C 
121 CTGGCCGTGGGCTTGAACCGCCGGCTCCGCAACCTGACCAATTGTTTCATCGTGTCCTTG 180 
T  C GT  T  c c T  G 
11 
181 GCTATCACTGACCTGCTCCTCGGCCTCCTGGTGCTGCCCTTCTCTGCCATCTACCAGCTG 240 
C T  G T  A 
241 TCCTGCAAGTGGA~TTTGGMGGTCTT~~~~~ATA~~T~~~~~~~~~T~GATGTGATG 300 
G C A T  T  
III 
301 CTCTGCACAGCCTCCATTCTTAACCTCTTCATGATCAGCCTCGACCGGTACTGCGCTGTC 360 
G G c c T  
361 ATGGACCCACTGCGGTACCCTGTGCTGGTCACCCCAGTTCGGGTCGCCATCTCTCTGGTC 420 
CT C C TA C G T  
I" 
421 TTAATTTGGGTCATCTCCATTACCCTGTCCTTTCTGTCTATCCACCTGGGGTGGAACAGC 480 
c C T  T  
481 AGGAACGAGACCAGCAAGGGCAATCATACCACCTCTAAGTGCA~GTCCAGGTCAATGAA 540 
T  G T T T  C TTC C CTTG 
v 
541 GTGTACGGGCTGGTGGATGGGCTGGTCACCTTCTACCTCCCGCTACTGATCATGTGCATC 600 
T  CT G G G 
601 ACCTACTACCGCATCTTCAAGGTCGCCCGGGCCAATCAATCACATTAGC 660 
AT c C GG 
661 TCCTGGAAGGCAGCCACCATCAGGGAGCACAARGCCACACAGTGACACTGGCCGCCGTCATG 720 
T  TG  T  A G 
VI 
721 GGGGCCTTCATCATCTGCTGGTTTCCCTACTTCACCGCGTTTGTGTACCGTGGGCTGAGA 780 
A A C T  T T  T  A 
VII 
781 GGGGATGATGCCATCAATGAGGTGTTAGAAGCCATCGTTCTGTGGCTGGGCTATGCCAAC 840 
CT T  G 
841 TCAGCCCTGAACCCCATCCTGTATGCTGCGCTGAACAGAGACTTCCGCACCGGGTACCAA 900 
G T  CA A G CA G 
901 CAGCTCTTCTGCTGCAGGCTGGCCAACCGCAACTCCCACAA~CTTCTCTGAGGTCCAAC 960 
C C G A TG  GG G 
961 GCCTCTCAGCTGTCCAGGACCCAAAGCCGAGAACCCCAGGCAACAGGAAGAGAAACCCCTG 1020 
AG G AT T  GG G 
1021 AAGCTCCAGGTGTGGAGTGGGACAG~GTCACGGCCCCCCAGGGAGCCACAGACAGGT~ 1080 
G A T  GA 
Fieure 2. The nucleotide sequence of the human H2 histamine receptor gene. The canine IX? 
histamine receptor gene was identical except as noted beneath the. human gene nucleotide sequence. 
The initiation codon (ATG) and termination codon (TAA) are italicized. The sequences encoding 
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Figure 3. Amino acid sequence of the human H2 histamine receptor. The canine H2 histamine 
receptor was identical except as noted by different amino acids beneath the human receptor 
sequence. The sequences encoding the seven putative transmembrane regions are indicated by the 
over lines. 
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TABLE I 
HOMOLOGY OF HUMAN AND CANINE IX! HISTAMINE RECEPTORS 
REGION NUCLEOTIDE 0 ACID 
(%IL=mTrY) (% SIMILARITY) (92 IDENTITY) 
TRANSMEMBRANE 




4 f; 100 
: E 100 96 2 
96 
7 86 95 86 
INTRACYTWLASMIC 
: ii; E 92 
90 








96 100 it 
literature there are only allusions as to the linkage of the human H2 to CAMP generation through a 
stixnulatory guanine nucleotide binding protein (Gs) (2), our data co&m this linkage. Studies by 
mutational analysis of the beta adrenergic region, which is associated with cAh4P generation via 
G,, indicate that the critical areas for interaction of the receptor protein to Gs resides in the AKR 
sequence of the amino terminus and the EHKA sequence at the carboxyl terminus of the third 
. 
4.8 kb - 
1.9 kb - 
Figure 4. Northern blot analysis of total RNA from human fundic mucosa (left) and transfected 
Colo-320 DM cells (right) with a random primed human H2 histamine receptor probe. 
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Figure 5. Methyl -[%-II tiotidine binding to transfected Cola-320DM cells. Binding was dose 
dependently reversed by cimetidine, while diphenhydramine and thioperamide had no effect. 
Tiotidine did not bind to non transfected Colo-320DM cells (data not shown). 
Effect of histamine on CAMP accumulation in transfected Cola-320DM cells. Histamine Fkure 6. 
dose dependently increased CAMP accumulation with a maximal effect and half maximal effect 
observed at lo-SM and 5xlWM respectively. Histamine’s stimulatory effect on CAMP generation 
was abolished by pretreatment with cimetidine (IO-SM). 
intracytoplasmic loop (10). Both the canine II2 histamine receptor, the action of which has been 
shown to be mediated via Gs, and the newly cloned human histamine II2 receptor conserve these 
amino acids. It is important to note, however, that the demonstrated linkage between II2 histamine 
receptors and CAMP generation does not preclude. mediation of histamine action via other signal 
transduction pathways. In a human leukemia cell line (HL60) and in isolated rabbit gastric parietal 
cells, activation of an intracellular pathway leading to tY2 mobilization has been identified 
(11,12). Further studies in cells transfected with a construct of our newly cloned human II2 
histamine receptor gene may determine whether the multiple signal transduction pathways activated 
by II2 receptors is mediated by a single or multiple receptor subtypes. 
The histamine II2 receptor plays a critically important role in numerous physiological 
functions. Antagonism of one of these functions, stimulation of gastric acid secretion, has been 
the basis of an enormous world-wide pharmaceutical industry market for treatment of acid/peptic 
disorders of the intestine. Structural and functional characterization of the human II2 histamine 
receptor via studies with the gene that we have successfully cloned may help to elucidate the 
pathogenesis of these disorders as well as aid in their treatment. 
ACKNOWLEDGMENTS 
This work was supported by NIH grant ROlDK34306, ROlDK33500 and funds from the 
University of Michigan Gastrointestinal Peptide Research Center (NM grant P30DK34933). Dr. 
Gantz is a recipient of a Veterans Administration Research Associate Award. Dr. Munzert is the 
recipient of the Deutsche Forschungsgemeinschaft grant Mu 835/1-l. Dr. Schtifer is recipient of 
the Deutsche Forschungsgemeinschaft grant Scha 453/1-l. Dr. DelValle is recipient of a Clinical 
Investigator Award (NIH grant KO8-DK01823). We thank Il Song for synthesizing our 
oligonucleotides. 
1391 






Feldman, M., Burton, M. E. (1990) New Engl. J. Med. 323, 1672-1680. 
Gantz, I., Schaffer, M., DelValle, J., Logsdon, C., Campbell, V., Uhler, M., Yamada, T. 
(1991) Proc. Nat. Acad. Sci. USA 88,429-433. 
Chomczynski, P., Sacchi, N. (1987) Anal. B&hem. 162, 156-159. 
Crouse, G. F., Frischauf, A., Lehrach, H. (1983) Methods in Enzymology 101,78-89. 






Feinberg, A. P.,Vogelstein, R. (1983) Anal. B&hem. 132.6 13. 
Brown, N. A., Steofko, R. E., Uhler, M. D. (1990) J. Biol. Chem. 265, 13181-13189. 
Okayama, H., Chen, C. (1987) Mol. Cell. Biol. 7, 2745-2752. 
Campbell, V.W., Del Valle, J., Hawn, M., Park, J., Yamada, T. (1989) Am. J. Physiol. 
256, G63 1 -G636. 
10. Strader, C. D., Sigal, I.S., Dixon, R. A. F. (1989) FASEB J 3, 1825-1832. 
11. Mitsuhashi, M., Mitsuhashi, T., Payan, D. B. (1989) J. Biol. Chem. 264, 18356-18362. 
12. Chew, C., Brown, M. R. (1989) Biochim. Biophys. Acta 888, 116-125. 
REFERENCES 
1392 
